MedPath
HSA Approval

BETOPTIC S STERILE OPHTHALMIC SUSPENSION 0.25%

SIN05837P

BETOPTIC S STERILE OPHTHALMIC SUSPENSION 0.25%

BETOPTIC S STERILE OPHTHALMIC SUSPENSION 0.25%

May 18, 1991

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01ED02

betaxolol

Manufacturer Information

NOVARTIS (SINGAPORE) PTE LTD

ALCON-COUVREUR NV

Active Ingredients

BETAXOLOL HCl EQV BETAXOLOL

0.25% w/v

Betaxolol

Documents

Package Inserts

Betoptic S PI.pdf

Approved: September 30, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.